Found: 11
Select item for more details and to access through your institution.
Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
- Published in:
- EMBO Journal, 2002, v. 21, n. 6, p. 1379, doi. 10.1093/emboj/21.6.1379
- By:
- Publication type:
- Article
Selective CD47 targeting with a bispecific antibody.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Lessons from bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression.
- Published in:
- Immunological Reviews, 2000, v. 178, n. 1, p. 148, doi. 10.1034/j.1600-065x.2000.17813.x
- By:
- Publication type:
- Article
Extracellular nicotinamide phosphoribosyltransferase: role in disease pathophysiology and as a biomarker.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1268756
- By:
- Publication type:
- Article
Chromatin remodeling and extragenic transcription at the MHC class II locus control region.
- Published in:
- Nature Immunology, 2003, v. 4, n. 2, p. 132, doi. 10.1038/ni883
- By:
- Publication type:
- Article
In vivo, RFX5 binds differently to the human leucocyte antigen-E, -F, and -G gene promoters and participates in HLA class I protein expression in a cell type-dependent manner.
- Published in:
- Immunology, 2004, v. 111, n. 1, p. 53, doi. 10.1111/j.1365-2567.2004.01783.x
- By:
- Publication type:
- Article
Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity.
- Published in:
- Antibodies (2073-4468), 2018, v. 7, n. 1, p. 3, doi. 10.3390/antib7010003
- By:
- Publication type:
- Article
Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01516-3
- By:
- Publication type:
- Article
CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model.
- Published in:
- Experimental Hematology & Oncology, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40164-022-00279-w
- By:
- Publication type:
- Article
Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 Κλ bispecific antibody.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1378813
- By:
- Publication type:
- Article
A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
- Published in:
- Nature Genetics, 1998, v. 20, n. 3, p. 273, doi. 10.1038/3081
- By:
- Publication type:
- Article